Leveraging its cutting-edge technology and
data, Hims & Hers looks to deliver unprecedented access to
personalized healthcare solutions
Hims & Hers Health, Inc. (“Hims & Hers” or the
“Company”) (NYSE: HIMS), the leading health and wellness platform,
today introduced MedMatch, a technology designed to transform
healthcare by giving providers a more intelligent and informed way
to deliver personalized care to patients with more effective and
precise treatments and medications.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231106108871/en/
MedMatch by Hims & Hers
Currently in Beta, MedMatch deploys artificial intelligence and
machine learning against the expansive dataset at the core of the
Hims & Hers platform. Leveraging millions of anonymized data
points from millions of customers, MedMatch models can identify
treatments in real-time that may be best suited for a patient’s
unique needs. The company is initially deploying MedMatch for
customers seeking support for anxiety and depression on the Hims
& Hers platform.
The U.S. is experiencing a mental health crisis. Many people
avoid seeking treatment due to stigma and lack of education for
psychiatric disorders. When treatment is sought, there is a
shortage of mental health professionals, creating an unacceptable
gap between need and access. Furthermore, when patients do receive
treatment, it can require multiple visits incurring time and
financial burdens, and the treatment is typically based on the
singular provider’s experience.
MedMatch is being developed to help providers on the platform
identify the optimal treatment for a particular person, which can
include the most appropriate treatment formulation to dosage
strength to form factor. Trained on anonymized historical clinical
visits, demographics, treatment types, and patient outcomes,
MedMatch is being built to have the unique ability to recommend
clinical decisions and treatments supported and informed by the
collective knowledge of thousands of providers and millions of data
points. We believe connecting the patient with the right
personalized treatment will result in better clinical outcomes,
leading to long-term patient happiness.
In this initial Beta phase, MedMatch is being evaluated on
independent metrics including remission rates once treatment
begins, time to remission, and patient satisfaction.
“We believe that key to our mission is building a foundation of
innovative technologies that empower providers to deliver a level
of clinical care unmatched by the traditional system,” said
Co-Founder and CEO Andrew Dudum. “At the heart of our work is
patient trust – trust in their provider, in their care plan, and in
their treatment to work. MedMatch is an incredibly exciting step in
transforming healthcare to truly serve the patient, and ultimately,
give the patient confidence in their care.”
As development of the MedMatch model continues, we plan to add
more robust capabilities and expand the model to additional health
categories on the Hims & Hers platform to progress towards the
ability to deliver this unprecedented standard of personalized care
to patients across a range of healthcare conditions. Stay tuned for
further developments and updates of this exciting new technology in
the months to come.
Learn more about MedMatch here.
Cautionary Note Regarding Forward-Looking Statements
This press release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements can be identified by the
use of forward-looking terminology, including the words “believe,”
“estimate,” “anticipate,” “expect,” “assume,” “imply,” “intend,”
“plan,” “may,” “will,” “potential,” “project,” “predict,”
“continue,” “could,” or “should,” or, in each case, their plural,
their negative or other variations or comparable terminology. There
can be no assurance that actual results will not materially differ
from expectations. Such statements include, but are not limited to,
any statements relating to our financial outlook and guidance,
including our mission to drive top-line growth and profitability
and our ability to attain our long-term financial targets; our
expected future financial and business performance, including with
respect to the Hims & Hers platform, our marketing campaigns,
investments in innovation, and our infrastructure, and the
underlying assumptions with respect to the foregoing; statements
relating to events and trends relevant to us, including with
respect to our financial condition, results of operations, short-
and long-term business operations, objectives, and financial needs;
expectations regarding our mobile applications, market acceptance,
user experience, customer retention, brand development, our ability
to invest and generate a return on any such investment, customer
acquisition costs, operating efficiencies and leverage (including
our fulfillment capabilities), the effect of any pricing decisions,
changes in our product or offering mix, the timing and market
acceptance of any new products or offerings, the success of our
business model, our market opportunity, our ability to scale our
business, the growth of certain of our categories, our ability to
innovate on and expand the scope of our offerings and experiences,
our ability to reinvest into the customer experience, and our
ability to comply with the extensive, complex and evolving
regulatory requirements applicable to our business, including
without limitation state and federal healthcare, privacy and
consumer protection laws and regulations. These statements are
based on management’s current expectations, but actual results may
differ materially due to various factors.
The forward-looking statements contained in this press release
are based on our current expectations and beliefs concerning future
developments and their potential effects on us. Future developments
affecting us may not be those that we have anticipated. These
forward-looking statements involve a number of risks, uncertainties
(some of which are beyond our control) and other assumptions that
may cause actual results or performance to be materially different
from those expressed or implied by these forward-looking
statements. These risks and uncertainties include, but are not
limited to, those factors described in the “Risk Factors” section
of each of our most recently filed Quarterly Report on Form 10-Q,
our most recently filed Annual Report on Form 10-K, and any of our
subsequent filings with the Securities and Exchange Commission (the
“Commission”).
Should one or more of these risks or uncertainties materialize,
or should any of our assumptions prove incorrect, actual results
may vary in material respects from those projected in these
forward-looking statements. We undertake no obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be required
under applicable securities laws.
By their nature, forward-looking statements involve risks and
uncertainties because they relate to events and depend on
circumstances that may or may not occur in the future. We caution
you that forward-looking statements are not guarantees of future
performance and that our actual results of operations, financial
condition and liquidity, and developments in the industry in which
we operate may differ materially from those made in or suggested by
the forward-looking statements contained in reports we have filed
or will file with the Commission, including our most recently filed
Annual Report on Form 10-K, our most recently filed Quarterly
Report on Form 10-Q, and any of our subsequent filings with the
Commission. In addition, even if our results of operations,
financial condition and liquidity, and developments in the industry
in which we operate are consistent with the forward-looking
statements contained in such reports, those results or developments
may not be indicative of results or developments in subsequent
periods.
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a
mission to help the world feel great through the power of better
health.
We believe how you feel in your body and mind transforms how you
show up in life. That’s why we’re building a future where nothing
stands in the way of harnessing this power. Hims & Hers
normalizes health & wellness challenges—and innovates on their
solutions—to make feeling happy and healthy easy to achieve. No two
people are the same, so the Company provides access to personalized
care designed for results.
For more information, please visit www.hims.com and
www.forhers.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231106108871/en/
Khobi Brooklyn Press@forhims.com
Hims and Hers Health (NYSE:HIMS)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Hims and Hers Health (NYSE:HIMS)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024